RE: Juhu interview17 Sep 2025 14:25
Just to be clear BMHLtd, I'm not insinuating anything at all and have no intention to offend. I'm just stating an opinion as do others who think we are being 'played'. The challenge, for the likes of me, is to weigh up the veracity of the information I read and to consider the motives, if any. I see lots of posts using AI to support the belief that Faron is worth x and will by bought out by y and take the same approach. Again, you have written 'I do believe offers will already be on the table ' and, unless you have inside knowledge, this is just speculation and us mere mortals, with far less of an insight into this space, can only assume as much. I'm not suggesting that you're either right or wrong in any of your assumptions etc. but making the point we can't know. I. for one, appreciate your contributions, but take them 'in the round' and take note of other sources that take a different view. Having read about the 80% drop in the SP in 2018 following the poor results of the Traumakine Phase 3 trials, I'm very much aware that things can change very quickly. My view is, on balance, that we have enough of a chance of being successful that it makes me stay invested.
I certainly agree with BMHLtd that Biotech is volatile and not for the faint-hearted.